Media coverage about Danaher (NYSE:DHR) has been trending somewhat positive this week, according to Accern. The research group identifies negative and positive media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Danaher earned a news impact score of 0.20 on Accern’s scale. Accern also assigned media stories about the conglomerate an impact score of 46.9325550640956 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Here are some of the media stories that may have effected Accern’s rankings:
- Pause, Trim, Reboot: GE Power Renders 12,000 Job Cuts (finance.yahoo.com)
- GE to Lay Off 4,500 Employees in Europe for Reducing Costs (finance.yahoo.com)
- Daily Dividend Report: SYK, ADC, MO, DHR, DE – Nasdaq (nasdaq.com)
- What the sentiment indicator is Signaling: Danaher Corporation (DHR), MannKind Corporation (MNKD) – Market Movers (financialqz.com)
- Investor’s Roundup (Intraday Analysis) – Danaher Corporation, (NYSE: DHR) – Stock Watch (stocksnewstimes.com)
Danaher (NYSE:DHR) traded up $0.50 during trading on Friday, hitting $93.18. The stock had a trading volume of 1,457,353 shares, compared to its average volume of 1,811,803. Danaher has a 1-year low of $77.45 and a 1-year high of $94.82. The company has a quick ratio of 1.00, a current ratio of 1.43 and a debt-to-equity ratio of 0.42. The stock has a market capitalization of $64,816.47, a price-to-earnings ratio of 23.95, a P/E/G ratio of 2.22 and a beta of 1.02.
Danaher (NYSE:DHR) last posted its quarterly earnings data on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, topping analysts’ consensus estimates of $0.95 by $0.05. Danaher had a return on equity of 11.29% and a net margin of 13.36%. The business had revenue of $4.53 billion for the quarter, compared to analyst estimates of $4.47 billion. During the same quarter in the prior year, the company earned $0.87 earnings per share. The company’s revenue was up 9.6% on a year-over-year basis. equities research analysts expect that Danaher will post 3.99 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, December 29th will be given a dividend of $0.14 per share. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.60%. The ex-dividend date of this dividend is Thursday, December 28th. Danaher’s dividend payout ratio is currently 16.52%.
A number of brokerages have issued reports on DHR. Cowen reissued a “buy” rating and issued a $90.00 target price on shares of Danaher in a research report on Wednesday, October 4th. J P Morgan Chase & Co reissued an “overweight” rating and issued a $95.00 target price on shares of Danaher in a research report on Friday, September 8th. Robert W. Baird boosted their target price on Danaher from $87.00 to $97.00 and gave the company an “outperform” rating in a research report on Friday, October 20th. Zacks Investment Research raised Danaher from a “hold” rating to a “buy” rating and set a $97.00 target price on the stock in a research report on Thursday, October 5th. Finally, Goldman Sachs Group reissued a “neutral” rating and issued a $83.00 target price on shares of Danaher in a research report on Tuesday, September 26th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $93.31.
In related news, Director Donald J. Ehrlich sold 10,578 shares of the stock in a transaction on Tuesday, October 24th. The stock was sold at an average price of $90.82, for a total value of $960,693.96. Following the transaction, the director now owns 104,621 shares of the company’s stock, valued at $9,501,679.22. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Daniel Raskas sold 37,870 shares of the stock in a transaction on Thursday, November 16th. The shares were sold at an average price of $93.33, for a total value of $3,534,407.10. The disclosure for this sale can be found here. Insiders sold 273,810 shares of company stock worth $25,218,813 in the last three months. 12.20% of the stock is currently owned by corporate insiders.
ILLEGAL ACTIVITY WARNING: This story was first reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of US & international copyright legislation. The correct version of this story can be read at https://www.thelincolnianonline.com/2017/12/10/danaher-dhr-earning-somewhat-favorable-news-coverage-accern-reports.html.
Danaher Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Corporation Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Danaher Corporation and related companies with MarketBeat.com’s FREE daily email newsletter.